4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-002521
CHIEF EXECUTIVE OFFICER gave up 625 shares (to pay taxes)
- CHIEF EXECUTIVE OFFICER acquired 1,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Williams Gregory C. CHIEF EXECUTIVE OFFICER | 2020-10-30 | Option exercise | +1,875 | 9,382 | D: show line 1 in the form | ||
| Williams Gregory C. CHIEF EXECUTIVE OFFICER | 2020-10-30 | Shares withheld for taxes | −625 | $2.53 | $1,581 | 8,757 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Williams Gregory C. CHIEF EXECUTIVE OFFICER | 2020-10-30 | Option exercise · Restricted Stock Units | −1,875 | 16,875 | D: show line 3 in the form |
Loading xslF345X03/form4-11022020_041107.xml…